2016
DOI: 10.1002/jgm.2935
|View full text |Cite
|
Sign up to set email alerts
|

Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1): Potential implications on future therapeutic intervention

Abstract: Background The symptoms of phosphoribosyl pyrophosphate synthetase 1 (PRPS1) deficiency diseases have been reported to be alleviated by medication. Herein, we report biochemical data to favor PRPS1 deficiency-related hearing loss as a potential target for pharmaceutical treatment. Methods We recruited 42 probands from subjects under the age of 15 years with a moderate degree of nonsyndromic autosomal-recessive or sporadic sensorineural hearing loss (SNHL) in at least one side. Molecular genetic testing, incl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 31 publications
0
15
0
Order By: Relevance
“…All 18 patients had congenital/early-onset SNHL, ID, muscular hypotonia, and muscle weakness, 17 had visual impairment, 16 had ataxia, 15 showed DD, 14 showed susceptibility to infections, 12 died in early childhood, four developed peripheral neuropathy, three presented with muscle weakness exacerbation after infections, two had seizures, and one developed behavioral disturbances. In addition, 10 male patients from four families with the classical symptom triad of CMTX5 (early-onset SNHL, peripheral neuropathy, and optic atrophy) [ [19] , [20] , [21] ], another 10 male patients from four families with only SNHL and peripheral neuropathy [ [22] , [23] , [24] ], and 36 male patients from eight families with DFN2 [ 23 , [25] , [26] , [27] , [28] ] with variants in the PRPS1 gene have been reported. Intrafamilial phenotypic variation was described in a Spanish family with nine affected males—all presented with prelingual severe-to-profound SNHL, but three males had additional features (global DD, mild ID, seizures, and clubfoot) [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…All 18 patients had congenital/early-onset SNHL, ID, muscular hypotonia, and muscle weakness, 17 had visual impairment, 16 had ataxia, 15 showed DD, 14 showed susceptibility to infections, 12 died in early childhood, four developed peripheral neuropathy, three presented with muscle weakness exacerbation after infections, two had seizures, and one developed behavioral disturbances. In addition, 10 male patients from four families with the classical symptom triad of CMTX5 (early-onset SNHL, peripheral neuropathy, and optic atrophy) [ [19] , [20] , [21] ], another 10 male patients from four families with only SNHL and peripheral neuropathy [ [22] , [23] , [24] ], and 36 male patients from eight families with DFN2 [ 23 , [25] , [26] , [27] , [28] ] with variants in the PRPS1 gene have been reported. Intrafamilial phenotypic variation was described in a Spanish family with nine affected males—all presented with prelingual severe-to-profound SNHL, but three males had additional features (global DD, mild ID, seizures, and clubfoot) [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…Most patients in the four families with DFNX1/DFN2 have postlingual progressive nonsyndromic hearing loss, though congenital profound nonsyndromic hearing loss was also reported in one family (Tyson et al, ; Manolis et al, ; Cui et al, ; Petersen et al, ; Liu et al, ; Liu et al, ; Kim et al, ). Among seven exons of PRPS1 encoding PRS‐I of 318 amino acids, four missense mutations of PRPS1 occur in both exon 2 (c.G193A, p.D65N; c.G259A, p.A87T) and exon 7 (c.T869C, p.I290T; c.G916A, p.G306R) (Liu et al, ).…”
mentioning
confidence: 98%
“…Although most female carriers in families with PRPS1 variants were noted to be asymptomatic (Kim et al, 2007), some studies report that female carriers in families with Arts syndrome or CMTX5 occasionally exhibit delayed onset hearing impairment, sometimes combined with ataxia and neuropathy (Almoguera et al, 2014;Arts, Loonen, Sengers, & Slooff, 1993;de Brouwer et al, 2010;Kim et al, 2016;Liu et al, 2010;Synofzik et al, 2014). In addition, a missense variant, p.Ser16Pro, has been reported in affected females in one family as the cause of optic atrophy, RP and neurological features overlapping CMTX5, and Arts syndrome, with no affected males (Almoguera et al, 2014).…”
Section: Discussionmentioning
confidence: 99%